Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
4 Patents
#14 in Vilnius
#16 in Lithuania
Uab Ferentis
Forward Citations = 10
9 inventors:
Uab Ferentis
EPO Patents = 4
Forward Citations = 10
Loading Chart...
Loading Chart...
9 inventors (with patents filed for the assignee):
Jaywant Babasaheb Phopase (3 out of 3 patents)
Ranjithkumar Ravichandran (2 out of 3 patents)
May Griffith (1 out of 1 patent)
4. Mohammad Mirazul Islam (1 out of 1 patent)
5. Ramunas Valiokas (1 out of 2 patents)
6. Vytautas Cepla (1 out of 2 patents)
7. Zivile Ruzele (1 out of 1 patent)
8. Tomas Rakickas (1 out of 1 patent)
9. Jaywant Phopase (1 out of 1 patent)
10. Jaywant Phopase (0 patent)
4 patents:
Company Overview
Uab Ferentis is a leading biotechnology company specializing in the development of innovative cell-based technologies for drug discovery, regenerative medicine, and tissue engineering. With a focus on personalized medicine, Ferentis aims to revolutionize the healthcare industry by providing cutting-edge solutions for a wide range of therapeutic applications.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Uab Ferentis. Retrieved from https://idiyas.com/company/uab-ferentis
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]